Skip to content
Home/Companies/MedTech/Cellnovo

Cellnovo

MedTech·France·Exited 2015·Held 4yr
Entry
2011
Hold
4yr
Exit
2015

Who owns Cellnovo?

Cellnovo was owned by Andera Partners through BioDiscovery 3 (2009 vintage) from 2011 to 2015, exited via IPO.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2015

More from BioDiscovery 3

Other portfolio companies in the same fund.

GenKyoTex
Exited 2014
BiotechFrance· 2011
Sapiens
Sapiens
Exited 2013
MedTechFrance· 2011
to
Covagen
Exited 2014
BiotechFrance· 2010
to
Parvulus Medical
Exited
MedTechFrance· 2010
Poxel
Poxel
Active
BiotechFrance· 2010
Endosense
Exited 2013
MedTechFrance· 2009
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Cellnovo

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cellnovo?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cellnovo.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue